TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20849317

Group type: EXPERIMENTAL
Intervention: iopromide 370
Number of subjects: 297

Group type: COMPARATOR
Intervention: iomeprol 400
Number of subjects: 297
Study: 17441846

Group type: EXPERIMENTAL
Intervention: Patch test with 15 microg Ni/cm(2) on large area
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Repeated open application test (ROAT) with 6.64 microg Ni/cm(2) on large area
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: ROAT threshold
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Patch test at higher concentrations of nickel
Number of subjects: 20
Study: 14674041

Group type: EXPERIMENTAL
Intervention: MRS of the lentiform nucleus in IPDUS patients
Number of subjects: 25

Group type: COMPARATOR
Intervention: MRS of the lentiform nucleus in healthy volunteers (control)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: MRS of the lentiform nucleus ipsilateral to the symptomatic side of the patient
Number of subjects: 25
Study: 11692906

Group type: EXPERIMENTAL
Intervention: Iloprost (intravenous infusion)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nifedipine (oral)
Number of subjects: 20
Study: 9164906

Group type: EXPERIMENTAL
Intervention: Single coil
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Multiple coils
Number of subjects: 100
Study: 8170842

Group type: EXPERIMENTAL
Intervention: Increased skin wetness
Number of subjects: 1601

Group type: EXPERIMENTAL
Intervention: Increased skin pH
Number of subjects: 1601

Group type: EXPERIMENTAL
Intervention: Minimized increases in both skin wetness and skin pH
Number of subjects: 1601
Study: 3266379

Group type: COMPARATOR
Intervention: ketorolac placebo/heparin placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ketorolac active/heparin placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ketorolac active/heparin active
Number of subjects: 12

Group type: COMPARATOR
Intervention: ketorolac placebo/heparin active
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: heparin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ketorolac
Number of subjects: 12
Study: 29771687

Group type: EXPERIMENTAL
Intervention: Memantine ER/ChEI
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo/ChEI
Number of subjects: 0
Study: 27111239

Group type: COMPARATOR
Intervention: Alendronate (ALN) 10 mg/day
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Teriparatide 20 μg/day
Number of subjects: 428
Study: 25503557

Group type: COMPARATOR
Intervention: Sevoflurane alone (control group)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: 1 µg/kg fentanyl (fent1 group)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: 2 µg/kg fentanyl (fent2 group)
Number of subjects: 93
Study: 22642686

Group type: EXPERIMENTAL
Intervention: Strength training group (4 weeks of heavy load squat strength training)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 12
Study: 20716717

Group type: EXPERIMENTAL
Intervention: Home Monitoring (HM)
Number of subjects: 1339
Study: 17620645

Group type: EXPERIMENTAL
Intervention: Household-based water treatment interventions
Number of subjects: 492

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 492
Study: 16302899

Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 880

Group type: COMPARATOR
Intervention: Control
Number of subjects: 880
Study: 12015391

Group type: EXPERIMENTAL
Intervention: t-PA (100 mg intravenously over 15 minutes)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Placebo (intravenously over 15 minutes)
Number of subjects: 233
Study: 10480411

Group type: EXPERIMENTAL
Intervention: Calcitriol (0.25 microg)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Calcitriol and Placebo (both groups)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Hypogonadism
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Calcitriol
Number of subjects: 132
Study: 8621278

Group type: EXPERIMENTAL
Intervention: 3D-CRT (78 Gy in 39 fractions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conven-RT (70 Gy in 35 fractions)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Overall study population
Number of subjects: 60
Study: 2021378

Group type: EXPERIMENTAL
Intervention: Cognitive procedures directed at changing misinterpretations of bodily sensations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive procedures not targeting misinterpretations
Number of subjects: 0
Study: 6958191

Group type: EXPERIMENTAL
Intervention: Product feedback (IBI X PTT) during dynamic exercise
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Product feedback (IBI X PTT) at rest
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: PTT feedback during isometric exercise
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Feedback training for anginal patients
Number of subjects: 7
Study: 31623051

Group type: EXPERIMENTAL
Intervention: LOP chemotherapy (asparaginase + vincristine + dexamethasone) combined with IMRT
Number of subjects: 60

Group type: COMPARATOR
Intervention: CHOP chemotherapy (cyclophosphamide + pirarubicin + vincristine + dexamethasone) combined with IMRT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: LOP chemotherapy combined with IMRT
Number of subjects: 60

Group type: COMPARATOR
Intervention: CHOP chemotherapy combined with IMRT
Number of subjects: 60
Study: 27814309

Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Medicine (OMM) bi-weekly for 6 weeks
Number of subjects: 11

Group type: COMPARATOR
Intervention: Weekly counseling sessions (placebo-control) for 6 weeks
Number of subjects: 11
Study: 26387858

Group type: EXPERIMENTAL
Intervention: Neck-specific exercise (NSE)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: NSE combined with a behavioral approach (NSEB)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Prescribed physical activity (PPA)
Number of subjects: 216
Study: 25064672

Group type: EXPERIMENTAL
Intervention: Individual flavor (single flavor group, n=25-26)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Variety of flavors (3 different flavors, n=50)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Overall compliance to the protocol
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 151
Study: 22021102

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Supervised exercise programme (SEP)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Combined treatment (PTA plus SEP)
Number of subjects: 178

Group type: COMPARATOR
Intervention: PTA
Number of subjects: 178

Group type: COMPARATOR
Intervention: SEP
Number of subjects: 178

Group type: COMPARATOR
Intervention: PTA plus SEP
Number of subjects: 178
Study: 18635705

Group type: EXPERIMENTAL
Intervention: Rivastigmine (4.5 mg po bid) and domperidone (10 mg po qd)
Number of subjects: 15
Study: 17598971

Group type: EXPERIMENTAL
Intervention: Barbiturate coma (Group A, 17 patients)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (Group B, 23 patients)
Number of subjects: 40
Study: 15044205

Group type: EXPERIMENTAL
Intervention: IFN‐gamma 1b (200 microg) thrice weekly for 6 months
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: IFN‐gamma 1b treatment
Number of subjects: 330
Study: 12501905

Group type: EXPERIMENTAL
Intervention: Zevin® (generic acyclovir)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Zovirax® (brand name acyclovir)
Number of subjects: 0
Study: 9862943

Group type: EXPERIMENTAL
Intervention: Admission to the chest-pain observation unit (CPU) with a strict protocol including aspirin, heparin, continuous ST-segment monitoring, determination of creatine kinase isoenzyme levels, six hours of observation.
Number of subjects: 424

Group type: COMPARATOR
Intervention: Routine hospital admission (monitored bed under the care of the cardiology service).
Number of subjects: 424
Study: 8092082

Group type: EXPERIMENTAL
Intervention: diet relatively high in fat + 30 mg dexfenfluramine (dF)
Number of subjects: 32

Group type: COMPARATOR
Intervention: diet relatively high in fat + placebo
Number of subjects: 32

Group type: COMPARATOR
Intervention: diet relatively high in carbohydrates
Number of subjects: 32
Study: 3963358

Group type: EXPERIMENTAL
Intervention: Neuroleptanaesthesia (NA group)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Continuous epidural combined with light general anaesthesia (epidural group)
Number of subjects: 50
Study: 30200973

Group type: EXPERIMENTAL
Intervention: Sequential POCUS-assisted protocol
Number of subjects: 7

Group type: COMPARATOR
Intervention: Parallel POCUS-assisted protocol
Number of subjects: 7
Study: 27771985

Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 4752

Group type: COMPARATOR
Intervention: On-pump CABG
Number of subjects: 4752
Study: 24877078

Group type: EXPERIMENTAL
Intervention: High-Intensity Resistance Training (HRT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Low-Intensity Resistance Training (LRT)
Number of subjects: 50
Study: 22297080

Group type: EXPERIMENTAL
Intervention: Intraoperative antimicrobial prophylaxis alone (cefazolin 1 g before the surgical incision and every 3 h as intraoperative supplements)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Extended antimicrobial prophylaxis (intraoperative administration plus cefazolin 1 g once after closure and twice daily for 2 postoperative days)
Number of subjects: 355
Study: 20501957

Group type: EXPERIMENTAL
Intervention: EPO (12,000 IU intravenous administration)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: EPO (12,000 IU intravenous administration) in LAD subgroup
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (saline administration)
Number of subjects: 36
Study: 18595418

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Bupropion plus nicotine patch
Number of subjects: 227
Study: 18651857

Group type: EXPERIMENTAL
Intervention: IPTp with sulfadoxine-pyrimethamine (SP)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Maternal anaemia (haematocrit <33%)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Placental malaria
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Maternal HIV RNA viral load
Number of subjects: 207
Study: 15163255

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 956

Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 956
Study: 11120523

Group type: COMPARATOR
Intervention: ABO-compatible maternal-fetal dyads
Number of subjects: 1661

Group type: EXPERIMENTAL
Intervention: ABO-incompatible maternal-fetal dyads
Number of subjects: 1661

Group type: EXPERIMENTAL
Intervention: Maternal blood groups A and B
Number of subjects: 1661

Group type: EXPERIMENTAL
Intervention: Maternal type O and neonate type B
Number of subjects: 1661

Group type: EXPERIMENTAL
Intervention: Type O mother and type B neonate combinations
Number of subjects: 1661
Study: 9339268

Group type: COMPARATOR
Intervention: 75 mg t.i.d. xanomeline
Number of subjects: 343

Group type: COMPARATOR
Intervention: xanomeline (dose-dependent)
Number of subjects: 343
Study: 8471827

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (200-300 mg/day)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Maprotiline (200-300 mg/day)
Number of subjects: 32
Study: 3535049

Group type: EXPERIMENTAL
Intervention: Combination of pivampicillin and pivmecillinam
Number of subjects: 96

Group type: COMPARATOR
Intervention: Pivampicillin alone
Number of subjects: 96
Study: 31045214

Group type: EXPERIMENTAL
Intervention: Current corrective messages
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: Industry Deception + Testimonial messages
Number of subjects: 803

Group type: COMPARATOR
Intervention: Industry Deception
Number of subjects: 803

Group type: COMPARATOR
Intervention: Industry Deception + Testimonial
Number of subjects: 803
Study: 31038232

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI) at 10°C for 10 minutes
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Partial-body cryotherapy (PBC) at -60°C for 30 seconds, -135°C for 2 minutes
Number of subjects: 20
Study: 29975601

Group type: EXPERIMENTAL
Intervention: High quantity of carbohydrate (CHO) at 1.5 g/kg body weight
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low quantity of carbohydrate (CHO) at 0.8 g/kg body weight
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High glycemic index (GI) CHO (75)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low glycemic index (GI) CHO (40)
Number of subjects: 0
Study: 26822146

Group type: EXPERIMENTAL
Intervention: bexarotene 300 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 24138546

Group type: EXPERIMENTAL
Intervention: Nut oil (n-3:n-6 ratio: 1.3 : 6.1)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Mixed oil (n-3:n-6 ratio: 0.6 : 5.7)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (T2DM-OAD)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Both oil groups (nut oil and mixed oil)
Number of subjects: 92
Study: 22661455

Group type: EXPERIMENTAL
Intervention: Family Satisfaction in the ICU (FS-ICU) and Single-Item Quality of Dying (QOD-1) questionnaires
Number of subjects: 1290

Group type: EXPERIMENTAL
Intervention: FS-ICU items with low ratings
Number of subjects: 1290
Study: 19458961

Group type: EXPERIMENTAL
Intervention: Combined strength and aerobic training (4 sessions/week: 2 strength, 2 aerobic) for 16 weeks
Number of subjects: 20
Study: 17962429

Group type: EXPERIMENTAL
Intervention: varenicline 1 mg twice a day
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study: 14726297

Group type: EXPERIMENTAL
Intervention: EX group (physical training)
Number of subjects: 140

Group type: COMPARATOR
Intervention: CO group (control)
Number of subjects: 140
Study: 11206672

Group type: EXPERIMENTAL
Intervention: CODAS‐Verapamil (200 mg)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: CODAS‐Verapamil (300 mg)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: CODAS‐Verapamil (400 mg)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: CODAS‐Verapamil (bedtime dosing)
Number of subjects: 257
Study: 9509195

Group type: EXPERIMENTAL
Intervention: Hypertonic saline and dextran (HSD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Isotonic saline
Number of subjects: 20
Study: 7826932

Group type: EXPERIMENTAL
Intervention: Psychological or sexual victimization by male dating partners
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experiences of sexual coercion, unwanted sexual touching, psychological abuse, and sexual abuse
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Generalized fear of crime
Number of subjects: 0
Study: 3279366

Group type: EXPERIMENTAL
Intervention: Levobunolol (0.5 or 1%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.5% Timolol (Control)
Number of subjects: 0
Study: 31818339

Group type: EXPERIMENTAL
Intervention: Transcutaneous vagus nerve stimulation (tVNS)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Sham-stimulation (Control)
Number of subjects: 63
Study: 30018118

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (1,200 IU/day)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study: 26692007

Group type: EXPERIMENTAL
Intervention: Exogenous melatonin (short-term use)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exogenous melatonin (long-term use)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exogenous melatonin (in children and adolescents)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exogenous melatonin (in pregnant and breast-feeding women)
Number of subjects: 0
Study: 25911117

Group type: EXPERIMENTAL
Intervention: Multidetector row CT (MDCT) with model-based iterative reconstruction (MBIR), no ECG triggering, tube voltage and tube current of 100 kV and 60 mA
Number of subjects: 200

Group type: COMPARATOR
Intervention: Multidetector row CT (MDCT) with adaptive statistical iterative reconstruction algorithm (ASIR), no ECG triggering, kV and mA tailored on patient BMI
Number of subjects: 200
Study: 22982467

Group type: EXPERIMENTAL
Intervention: learner-generated drawing
Number of subjects: 108
Study: 20359843

Group type: EXPERIMENTAL
Intervention: diacetylmorphine
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: hydromorphone
Number of subjects: 140
Study: 18237589

Group type: EXPERIMENTAL
Intervention: Blood glucose <81 mg/dl (hypoglycemia)
Number of subjects: 3491

Group type: EXPERIMENTAL
Intervention: Blood glucose >199 mg/dl (severe hyperglycemia)
Number of subjects: 3491

Group type: COMPARATOR
Intervention: Blood glucose 81 to 99 mg/dl (euglycemic group)
Number of subjects: 3491

Group type: EXPERIMENTAL
Intervention: Blood glucose 81 to 99 mg/dl
Number of subjects: 3491

Group type: EXPERIMENTAL
Intervention: Blood glucose >199 mg/dl
Number of subjects: 3491

Group type: EXPERIMENTAL
Intervention: Blood glucose 150 to 199 mg/dl
Number of subjects: 3491
Study: 16740516

Group type: EXPERIMENTAL
Intervention: Intervention designed to reinforce tobacco abstinence
Number of subjects: 765
Study: 11863094

Group type: EXPERIMENTAL
Intervention: Original CISCA/VB regimen (100% dose)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Low-dose CISCA/VB regimen (80% dose)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 125
Study: 10469180

Group type: EXPERIMENTAL
Intervention: Preparation A (single viral inactivated concentrate) - 32.5 IU kg-1
Number of subjects: 15

Group type: COMPARATOR
Intervention: Preparation B (double viral inactivated concentrate) - 27 IU kg-1
Number of subjects: 15
Study: 7554704

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg for 1 day and 250 mg for 4 subsequent days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Terfenadine 60 mg twice daily for 12 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Azithromycin and placebo
Number of subjects: 0
Study: 2177216

Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate (BDP) 400 micrograms day‐1
Number of subjects: 13

Group type: COMPARATOR
Intervention: Inhaled nedocromil sodium (NDS) 16 mg day‐1
Number of subjects: 13
Study: 6986893

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (substituted for bromocriptine)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Bromocriptine (after stopping therapy)
Number of subjects: 9
Study: 30496423

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including an educational session, a decision tool, an information booklet, and an online video.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (childcare-as-usual)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study: 28509812

Group type: EXPERIMENTAL
Intervention: Ospemifene 60 mg
Number of subjects: 2166
Study: 26229119

Group type: EXPERIMENTAL
Intervention: Cell phone intervention
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Personal coaching intervention
Number of subjects: 365

Group type: COMPARATOR
Intervention: Usual-care control group
Number of subjects: 365
Study: 23375753

Group type: COMPARATOR
Intervention: Plant sterol-enriched margarine (3.0 g/d of plant sterols)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Plant stanol-enriched margarine (3.0 g/d of plant stanols)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Control margarine
Number of subjects: 43
Study: 21273909

Group type: EXPERIMENTAL
Intervention: Sling exercise (SE) warm-up
Number of subjects: 16

Group type: COMPARATOR
Intervention: Thrower's 10 warm-up
Number of subjects: 16
Study: 19617211

Group type: EXPERIMENTAL
Intervention: Taping of the shoulder
Number of subjects: 33
Study: 16969707

Group type: EXPERIMENTAL
Intervention: Rebeccamycin analog 500 mg/m2 IV bolus every 21 days (arm 1)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Rebeccamycin analog 140 mg/m2 IV bolus daily x 5 days, every 21 days (arm 2)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 42
Study: 15136950

Group type: EXPERIMENTAL
Intervention: Metformin 1000 mg/day
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Metformin 1700 mg/day
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 103
Study: 11743513

Group type: EXPERIMENTAL
Intervention: Child-reported health status and QOL scores from the Pediatric Asthma Quality of Life Questionnaire after 12 months of randomization.
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Child's anxiety level, age, sex, and symptom exaggeration/minimization tendencies as predictors of QOL.
Number of subjects: 339
Study: 9261762

Group type: EXPERIMENTAL
Intervention: Alcohol 70%
Number of subjects: 109

Group type: COMPARATOR
Intervention: Alcoholic iodine 2%
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Theophylline with prednisone infusion
Number of subjects: 109

Group type: COMPARATOR
Intervention: Prednisone infusion alone
Number of subjects: 109
Study: 8410926

Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 27

Group type: COMPARATOR
Intervention: CT
Number of subjects: 27
Study: 3554560

Group type: EXPERIMENTAL
Intervention: Forskolin 1.0% eye drops
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Forskolin 1% eye drops
Number of subjects: 10
Study: 31984478

Group type: EXPERIMENTAL
Intervention: Anterior suprascapular nerve block
Number of subjects: 84

Group type: COMPARATOR
Intervention: Posterior suprascapular nerve block
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 84
Study: 31310919

Group type: EXPERIMENTAL
Intervention: Third trimester ultrasound for screening of fetal growth restriction (FGR)
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Timing of third trimester ultrasound
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Symphysis-fundus distance measurement accuracy
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Impact of third trimester ultrasound on cesarean delivery rate for fetal distress
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Impact of routine ultrasound on admission rate to neonatal intensive care unit
Number of subjects: 573